Diseases, Conditions, Syndromes

Authors pull study flagging hydroxychloroquine risks

The Lancet on Thursday retracted a study that raised safety fears over the use of a drug favored by President Donald Trump to treat COVID-19, after the paper's authors said they could no longer vouch for its underlying data.

Medications

Scientists raise concern over hydroxychloroquine study

Dozens of scientists have raised concerns over a large-scale study of hydroxychloroquine and chloroquine published in the Lancet that led to the World Health Organization suspending clinical trials of the anti-viral drugs ...

page 1 from 6